Given that PDAC features prominent stromal hyperplasia and hypoxia, the actual function of HYAL1 during tumor progression might be compromised or masked by compensatory mechanisms involving other hyaluronidases such as KIAA1199. The gene discussed is HYAL1; the disease is neoplasm.